Granules India Faces Growth Challenges Amid Shift to Sideways Stock Trend
Granules India, a small-cap pharmaceutical company, has undergone a recent evaluation adjustment reflecting changes in its stock's technical landscape. Despite facing growth challenges, the company demonstrates strong management efficiency and a solid ability to service debt, while trading at a discount compared to peers.
Granules India, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced an adjustment in its evaluation. This revision reflects a shift in the technical landscape surrounding the stock, moving from a mildly bullish stance to a sideways trend. Key financial metrics indicate that the company has faced challenges in maintaining growth, with net sales increasing at an annual rate of 10.50% and operating profit at 9.06% over the past five years. The most recent quarter, Q1 FY25-26, reported flat financial performance, and the return on capital employed (ROCE) for the half-year is noted at 14.17%, which is the lowest in recent times.
Despite these challenges, Granules India showcases strong management efficiency, evidenced by a high ROCE of 18.77% and a low debt-to-EBITDA ratio of 0.91 times, indicating a solid ability to service debt. The stock is currently trading at a discount compared to its peers' average historical valuations, with institutional holdings at 36.77%, suggesting a robust analytical capability among these investors.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
